糖尿病合并慢性肾脏病患者肾小管疾病生物标志物与终末期肾病风险
在REGARDS研究的病例-队列设计中,纳入560名糖尿病且基线eGFR<60 ml/min/1.73 m²的成人,随访4.3±2.7年,评估尿液肾小管损伤、炎症纤维化及功能标志物与终末期肾病(ESKD)的关联。调整eGFR和尿白蛋白后,尿KIM-1、α1m和MCP-1每升高2倍分别与ESKD独立相关(HR分别为1.43、1.47、1.27);LASSO回归保留KIM-1和α1m。
要点
- 在糖尿病合并CKD患者中,尿KIM-1、α1m和MCP-1升高与ESKD风险独立相关。
- 调整基线eGFR和尿白蛋白后,每2倍升高的HR:KIM-1 1.43,α1m 1.47,MCP-1 1.27。
- LASSO回归筛选出KIM-1和α1m与ESKD关联最强。
核心结论
- 在糖尿病且eGFR<60 ml/min/1.73 m²的成人中,较高的尿KIM-1、α1m和MCP-1与发生ESKD独立相关,为糖尿病合并CKD的疾病进展提供了见解。
研究设计与样本
- 采用病例-队列设计,从REGARDS研究1092名糖尿病且基线eGFR<60 ml/min/1.73 m²的成人中随机选取560名组成亚队列,并登记随访期间共161例ESKD(亚队列内93例,亚队列外68例),平均随访4.3±2.7年。
主要发现
- 基线时亚队列参与者平均年龄70±9岁,平均eGFR 40±13 ml/min/1.73 m²,尿白蛋白与肌酐比值中位数33(四分位距10-213)mg/g。
- 调整基线eGFR和尿白蛋白后,尿KIM-1每升高2倍与ESKD风险相关(HR=1.43,95%CI:1.17-1.75)。
- 调整基线eGFR和尿白蛋白后,尿α1m每升高2倍与ESKD风险相关(HR=1.47,95%CI:1.19-1.82)。
- 调整基线eGFR和尿白蛋白后,尿MCP-1每升高2倍与ESKD风险相关(HR=1.27,95%CI:1.06-1.53)。
- LASSO回归保留KIM-1和α1m与ESKD的关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tubulointerstitial damage in diabetes and chronic kidney disease (CKD) is poorly captured by estimated glomerular filtration rate (eGFR) and albuminuria. Urine biomarkers of kidney health may better elucidate disease progression in persons with diabetes and CKD. METHODS: Per case-cohort design, we randomly selected a subcohort of 560 study participants of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study from 1092 adults with diabetes and baseline eGFR <60 ml/min per 1.73 m2 and registered a total of 161 end-stage kidney disease (ESKD) cases (n = 93 from the subcohort; n = 68 from outside the subcohort) during 4.3 ± 2.7 years mean follow-up. We measured urine biomarkers of kidney tubule injury (kidney injury molecule-1 [KIM-1]), inflammation and fibrosis (monocyte chemoattractant protein-1 [MCP-1]), repair (chitinase-3-like protein 1 [YKL-40]), and tubule function, including reabsorption (alpha-1-microglobulin [α1m]) and synthetic capacity (epidermal growth factor [EGF] and uromodulin [UMOD]). Weighted Cox regression models estimated ESKD risk adjusting for demographics, ESKD risk factors, and baseline eGFR and urine albumin. Least absolute shrinkage and selection operator (LASSO) regression identified a subset of biomarkers most strongly associated with ESKD. RESULTS: At baseline, subcohort participants had mean age of 70 ± 9 years, mean eGFR of 40 ±13 ml/min per 1.73 m2, and median urine albumin-to-creatinine ratio of 33 (interquartile range 10-213) mg/g. Adjusting for baseline eGFR and albuminuria, each 2-fold higher urine KIM-1 (hazard ratio = 1.43 [95% CI: 1.17-1.75]), α1m (hazard ratio = 1.47 [1.19-1.82]), and MCP-1 (hazard ratio = 1.27 [1.06-1.53]) were independently associated with ESKD. LASSO retained KIM-1 and α1m for associations with ESKD. CONCLUSION: Among adults with diabetes and eGFR <60 ml/min per 1.73 m2, higher urine KIM-1, α1m, and MCP-1 are independently associated with incident ESKD, providing insight into kidney disease progression in persons with diabetes and CKD.
引用
- Amatruda JG, Katz R, Sarnak MJ, et al. Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD. Kidney Int Rep. 2022. PMID: 35812302. doi:10.1016/j.ekir.2022.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。